WS
TOVX icon

Wedbush Securities’s Theriva Biologics TOVX Stock Holding History

Wedbush Securities’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-526
Closed -$67K – 1006
2019
Q4 		$67K Buy
526
+100
+23% +$10.6K 0.01% 950
2019
Q3 		$48K Buy
426
+34
+9% +$4.11K ﹤0.01% 942
2019
Q2 		$54K Buy
+392
New +$56.4K 0.01% 944
2018
Q3 		– Sell
-15
Closed -$32K – 943
2018
Q2 		$32K Hold
15
– – ﹤0.01% 852
2018
Q1 		$42K Buy
15
+6
+67% +$22.8K 0.01% 789
2017
Q4 		$39K Buy
9
+3
+50% +$18.7K ﹤0.01% 827
2017
Q3 		$46K Sell
6
-1
-14% -$5.78K 0.01% 808
2017
Q2 		$35K Buy
7
+1
+17% +$4.98K ﹤0.01% 812
2017
Q1 		$31K Buy
6
+5
+500% +$34.9K ﹤0.01% 820
2016
Q4 		$8K Sell
1
-2
-67% -$20.5K ﹤0.01% 814
2016
Q3 		$38K Hold
3
– – 0.01% 801
2016
Q2 		$40K Hold
3
– – 0.01% 742
2016
Q1 		$52K Hold
3
– – 0.01% 698
2015
Q4 		$50K Hold
3
– – 0.01% 682
2015
Q3 		$50K Buy
3
+2
+200% +$49.2K 0.01% 664
2015
Q2 		$34K Hold
1
– – 0.01% 701
2015
Q1 		$26K Hold
1
– – ﹤0.01% 717
2014
Q4 		$18K Buy
+1
New +$13.4K ﹤0.01% 701

Other funds holding TOVX

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $4.23B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wedbush Securities's TOVX Position: Q1 2020 in Review

Wedbush Securities sold out of Theriva Biologics (TOVX) in Q1 2020, closing a stake of 526 shares — an estimated $67K sold.

Wedbush Securities first reported a position in TOVX in Q4 2014 and held it in 18 quarters. The position peaked at $67K in Q4 2019. 18 funds tracked by Wall St. Rank hold TOVX as of Q1 2020.

  • Wedbush Securities reported no remaining Theriva Biologics position as of Q1 2020 after selling out during the quarter.
  • Wedbush Securities sold 526 Theriva Biologics shares in Q1 2020, an estimated $67K.
  • Wedbush Securities first reported a position in Theriva Biologics in Q4 2014 and held it in 18 quarters.
  • Wedbush Securities's Theriva Biologics position peaked at $67K in Q4 2019.
  • 18 funds tracked by Wall St. Rank held Theriva Biologics as of Q1 2020.

Based on Wedbush Securities's 13F filing for Q1 2020, filed 17 Apr 2020.